Surgical reconstruction of the medial ulnar collateral ligament (UCL) of the elbow, colloquially referred to as "Tommy John surgery," has become more prevalent over the past 2 decades among professional baseball pitchers.^[@bibr4-2325967119864104],[@bibr20-2325967119864104],[@bibr30-2325967119864104],[@bibr31-2325967119864104]^ An estimated 25% of Major League Baseball (MLB) pitchers and 15% of Minor League Baseball (MiLB) pitchers report having previously undergone the procedure.^[@bibr5-2325967119864104]^ Although it is well established that the incidence of primary UCL reconstruction is rising, recent epidemiologic data have shown that revision rates may be increasing at a rate that outpaces primary procedures.^[@bibr7-2325967119864104],[@bibr21-2325967119864104]^ Although these increasing rates are well documented at the professional level (MLB and MiLB), even more concerning is that the greatest increase in surgical rates has been observed in adolescent and teenage players.^[@bibr12-2325967119864104],[@bibr15-2325967119864104]^ As pitchers are starting to undergo primary UCL surgery at younger ages, concern has arisen that many will be more likely to require revision surgery at an earlier age as well.

Sustained rates of return to play (RTP) among MLB pitchers who have undergone revision UCL reconstruction range from 42.3% to 78.0%,^[@bibr17-2325967119864104],[@bibr21-2325967119864104],[@bibr24-2325967119864104],[@bibr25-2325967119864104]^ and the average time to RTP after revision UCL reconstruction ranges from 18.9 to 20.76 months.^[@bibr17-2325967119864104],[@bibr21-2325967119864104]^ A number of studies have shown that revision UCL reconstruction results in decreased RTP rates and shortened careers following return, compared with primary reconstruction.^[@bibr6-2325967119864104],[@bibr17-2325967119864104],[@bibr21-2325967119864104],[@bibr25-2325967119864104]^ Although player performance metrics for both primary and revision UCL reconstruction have been shown to decline following surgery,^[@bibr17-2325967119864104],[@bibr21-2325967119864104],[@bibr24-2325967119864104]^ more robust outcomes and performance data are needed for players undergoing revision surgery.

For primary UCL reconstructions, 2 commonly used techniques are the docking technique and the modified Jobe technique.^[@bibr29-2325967119864104]^ The most commonly used grafts are either the palmaris longus tendon or one of the hamstring tendons (gracilis vs semitendinosus).^[@bibr2-2325967119864104],[@bibr18-2325967119864104],[@bibr19-2325967119864104],[@bibr29-2325967119864104]^ However, no consensus is available regarding optimal surgical technique, graft selection, tunnel configuration, or other surgical variables for revision UCL reconstruction. These data are critical because an improved understanding of the epidemiologic patterns, surgical practices, and outcomes data for revision UCL reconstruction in professional baseball pitchers will help guide clinical practice and optimize results. Accordingly, the purposes of this study were to (1) discuss surgical trends in revision UCL reconstruction among professional baseball pitchers over time, (2) identify the most commonly used surgical techniques in terms of graft type and tunnel configuration for revision surgery, and (3) describe overall outcomes of the procedure and compare them across the most commonly used surgical techniques and graft types.

Methods {#section1-2325967119864104}
=======

The MLB Health and Injury Tracking System (HITS) was accessed to identify all professional baseball (MLB and MiLB) pitchers who were listed as undergoing revision UCL reconstruction between 2010 (the first year HITS was established) and 2016. Nonpitchers were excluded. Player demographics, injury characteristics, surgical details, and player outcomes were analyzed. All data were obtained and analyzed in a completely anonymous and de-identified fashion. Because of the de-identified nature of the data, institutional review board approval was waived by the Mayo Clinic.

Player demographics included age at the time of surgery, throwing side dominance, pitching role (starter vs reliever), date of first professional contract, level of play (MLB vs MiLB), retirement date (if retired prior to 2017), date of primary surgery, and date of revision surgery. Operative reports were reviewed to determine the following surgical details: type of graft used (allograft vs autograft), graft source (eg, palmaris longus, hamstring tendon), tunnel configuration (eg, modified Jobe, docking technique), and concomitant procedures. Concomitant procedures were classified into the following categories: ulnar nerve surgery, debridement of posteromedial impingement (ulnohumeral impingement), flexor-pronator tendon repair, loose body removal, cartilage surgery, treatment of olecranon fractures, and biological augmentation (eg, stem cell injection, platelet-rich plasma).

The following outcomes measures were assessed: RTP status, time to RTP, return to same level (RSL) status, and time to RSL. Players were evaluated over time to see whether they developed subsequent elbow or forearm injuries. For the analysis of subsequent injuries, any elbow or forearm injury that occurred after the player achieved RTP and resulted in at least 1 day out of play was included. The need for subsequent surgery to the elbow (including repeat revision UCL reconstruction and non-UCL reconstruction procedures) or forearm was also assessed. Although all players were included in the analysis of surgical trends, only players with a minimum follow-up of 2 years (ie, surgery between 2010 and 2014) were included in the RTP and outcomes analysis.

Statistical Analysis {#section2-2325967119864104}
--------------------

General epidemiologic data are reported using standard descriptive statistics such as number, frequency, range, means with standard deviations, and medians. Comparisons were made between groups based on level of play at the time of surgery (MLB vs MiLB), type of graft (palmaris longus autograft vs hamstring autograft), and tunnel configuration (modified Jobe vs docking techniques). The differences in RTP, RSL, subsequent injury, and subsequent injury rates were compared between groups by use of a 2-tailed Fisher exact test. Pairwise comparisons between means were assessed using an unpaired Student *t* test, and these results are reported with their corresponding mean differences (MDs), 95% CIs, and *P* values. Linear regression was used to determine the significance of trends over time, and the corresponding *R* ^2^ and *P* values are provided. For all comparisons, *P* values less than .05 were considered to represent statistical significance.

Results {#section3-2325967119864104}
=======

From 2010 to 2016, a total of 69 professional baseball pitchers underwent revision UCL reconstruction at an average of 1424 days (47 months) after their primary surgery. The mean age at the time of revision was 26.3 years (range, 19.5-40.4 years), and 37.7% (n = 26) were MLB pitchers whereas 62.3% (n = 43) were MiLB pitchers. Additional demographic data are listed in [Table 1](#table1-2325967119864104){ref-type="table"}. The greatest number of procedures were performed in 2014 (n = 16), and the fewest were performed in 2010 and 2011 (n = 4 for each) ([Figure 1A](#fig1-2325967119864104){ref-type="fig"}). Although a general trend was seen toward increasing numbers of revision surgeries over time, this did not reach statistical significance (*R* ^2^ = 0.441; *P* = .104). When case distribution was assessed by month, April (20.3%), July (15.9%), and June (13.0%) were the highest volume months ([Figure 1B](#fig1-2325967119864104){ref-type="fig"}).

###### 

Demographics for All Professional Pitchers Undergoing Revision Ulnar Collateral Ligament Reconstruction From 2010 to 2016*^a^*

![](10.1177_2325967119864104-table1)

  -------------------------------------------------------------------------
                                       n    Mean ± SD        Median\
                                                             (Min, Max)
  ------------------------------------ ---- ---------------- --------------
  Age, y                               69   26.3 ± 4.2       25.3\
                                                             (19.5, 40.4)

  Time from signing to surgery, d      69   2147 ± 1613.0\   1803\
                                            (70 months)      (44, 7167)

  Time from primary to revision, d     69   1424 ± 1184.0\   971\
                                            (47 months)      (315, 5665)

  Postsurgical career length, y*^b^*   32   1.7 ± 1.3        3\
                                                             (0, 5)

                                       n    \%                

  Handedness                                                  

   Right                               52   75.4              

   Left                                17   24.6              

  Primary role                                                

   Starter                             42   60.9              

   Reliever                            27   39.1              

  Level at time of surgery                                    

   MLB                                 26   37.7              

   MiLB                                43   62.3              

  Graft type                                                  

   Autograft palmaris longus           22   31.9              

   Autograft hamstring tendon          34   49.3              

   Unknown or other                    13   18.8              

  Tunnel configuration                                        

   Docking                             17   24.6              

   Modified Jobe                       41   59.4              

   Unknown                             11   15.9              
  -------------------------------------------------------------------------

*^a^*Max, maximum; MiLB, Minor League Baseball; Min, minimum; MLB, Major League Baseball.

*^b^*Only players who retired prior to the 2017 season were eligible for postsurgical career length calculations.

![(A) A trend was found toward increasing number of revision ulnar collateral ligament (UCL) surgeries performed over time (*R* ^2^ = 0.441; *P* = .104). (B) The monthly distribution of surgical cases demonstrates that most operations were performed from March to July.](10.1177_2325967119864104-fig1){#fig1-2325967119864104}

In terms of the surgical procedure, the most common graft sources used were hamstring tendon autograft (n = 34; 49.3%) and palmaris longus autograft (n = 22; 31.9%) ([Table 1](#table1-2325967119864104){ref-type="table"}, [Figure 2A](#fig2-2325967119864104){ref-type="fig"}). No significant differences were found in the types of grafts used over time (*P* = .185 for palmaris and *P* = .175 for hamstring). The majority of cases were performed with the modified Jobe technique (n = 41; 59.4%) or the docking technique (n = 17; 24.6%) ([Table 1](#table1-2325967119864104){ref-type="table"}, [Figure 2B](#fig2-2325967119864104){ref-type="fig"}), and the frequency of each technique was steady over time (*P* = .891 and .857, respectively). The 11 remaining cases were performed with an unspecified tunnel configuration. In total, 48 (69.6%) pitchers had at least 1 concomitant procedure at the time of revision UCL reconstruction; 28 (40.6%) had a single concomitant procedure, whereas 13 (18.8%) pitchers had 2 concomitant procedures, and 7 (10.1%) pitchers had 3 concomitant procedures. The most common concomitant procedures were ulnar nerve surgery (n = 36; 52.2%), debridement of posteromedial impingement (n = 15; 21.7%), biological augmentation (n = 15; 21.7%), flexor-pronator tendon repair (n = 7; 10.1%), and loose body removal (n = 2; 2.9%).

![Trends in (A) graft source and (B) tunnel configuration over time for revision ulnar collateral ligament surgery.](10.1177_2325967119864104-fig2){#fig2-2325967119864104}

In terms of outcomes, 76.6% (n = 36/47) of eligible pitchers undergoing revision UCL reconstruction were able to RTP at any level, and 55.3% (n = 26/47) were able to RSL ([Table 2](#table2-2325967119864104){ref-type="table"}). The mean time to RTP was 484 days (16 months; median, 446.5 days) compared with a mean time to RSL of 518 days (17 months; median, 489.5 days) (MD, 34 days; 95% CI, --36.1 to 104.1 days; *P* = .336). The frequencies of subsequent injuries and surgeries are listed in [Table 2](#table2-2325967119864104){ref-type="table"}. A comparison of outcomes based on graft type (palmaris vs hamstring) is provided in [Table 3](#table3-2325967119864104){ref-type="table"}. Ultimately, the mean time to RTP was 436 days (14.5 months) for the palmaris group versus 540 days (18 months) for the hamstring group (MD, 103.6 days; 95% CI, --24.3 to 231.5 days; *P* = .108). No significant differences were found in RTP rates, subsequent injuries, or subsequent surgeries based on graft type ([Table 3](#table3-2325967119864104){ref-type="table"}). Similar results were noted for the comparison between tunnel configurations ([Table 4](#table4-2325967119864104){ref-type="table"}). Mean time to RTP at any level was 423 days (14 months) for the docking technique versus 519 days (17 months) for the modified Jobe technique (MD, 96.6 days; 95% CI, --88.8 to 282.0; *P* = .296). Similar rates of subsequent injuries and surgeries were noted between the 2 revision techniques ([Table 4](#table4-2325967119864104){ref-type="table"}).

###### 

Outcomes for the 47 Pitchers Undergoing Revision UCL Reconstruction From 2010 to 2014*^a^*

![](10.1177_2325967119864104-table2)

  -----------------------------------------------------------------------
                                         n    Mean ± SD     Median\
                                                            (Min, Max)
  -------------------------------------- ---- ------------- -------------
  Days to return to play                 36   484 ± 117.3   446.5\
                                                            (146, 1115)

  Days to return to play at same level   26   518 ± 158.9   489.5\
                                                            (221, 950)

                                         n    \%             

  Return to play at any level                                

   Yes                                   36   76.6           

   No                                    11   23.4           

  Return to play at same level                               

   Yes                                   26   55.3           

   No                                    21   44.7           

  Subsequent elbow injury                                    

   Yes                                   14   29.8           

   No                                    33   70.2           

  Subsequent forearm injury                                  

   Yes                                   3    6.4            

   No                                    44   93.6           

  Subsequent elbow surgery                                   

   Yes                                   10   21.3           

   No                                    37   78.7           

  Repeat revision UCL reconstruction                         

   Yes                                   3    6.4            

   No                                    44   93.6           
  -----------------------------------------------------------------------

*^a^*For all return to play and subsequent injury/surgery calculations, only players undergoing surgery between 2010 and 2014 were included. Max, maximum; Min, minimum; UCL, ulnar collateral ligament.

###### 

Comparisons of Outcomes Based on Type of Autograft Tendon Used (Autograft Palmaris Longus vs Autograft Hamstring Tendons)*^a^*

![](10.1177_2325967119864104-table3)

  ---------------------------------------------------------------------------------------------
                                         n        Mean ± SD     Mean Difference\    *P* Value
                                                                (95% CI)            
  -------------------------------------- -------- ------------- ------------------- -----------
  Days to return to play at any level                                                

   Palmaris longus                       13       436 ± 91.5    103.6\              .108
                                                                (--24.3 to 231.5)   

   Hamstring                             16       540 ± 208.5                       

  Days to return to play at same level                                               

   Palmaris longus                       10       510 ± 144.7   68.9\               .328
                                                                (--74.8 to 212.6)   

   Hamstring                             11       579 ± 167.5                       

                                         Yes, n   No, n         \% Yes              *P* Value

  Return to play at any level                                                        

   Palmaris longus                       13       6             68.4                .727

   Hamstring                             16       5             76.2                

  Return to play at same level                                                       

   Palmaris longus                       10       9             52.6                .999

   Hamstring                             11       10            52.4                

  Subsequent elbow injury                                                            

   Palmaris longus                       3        16            15.8                .163

   Hamstring                             8        13            38.1                

  Subsequent forearm injury                                                          

   Palmaris longus                       0        19            0.0                 .489

   Hamstring                             2        19            9.5                 

  Subsequent elbow surgery                                                           

   Palmaris longus                       2        17            10.5                .241

   Hamstring                             6        15            28.6                

  Subsequent UCL reconstruction                                                      

   Palmaris longus                       1        18            5.3                 .999

   Hamstring                             2        19            9.5                 
  ---------------------------------------------------------------------------------------------

*^a^*UCL, ulnar collateral ligament.

###### 

Comparisons of Outcomes Based on Tunnel Configuration (Docking vs Modified Jobe Techniques)*^a^*

![](10.1177_2325967119864104-table4)

  ----------------------------------------------------------------------------------------------
                                         n        Mean ± SD     Mean Difference\     *P* Value
                                                                (95% CI)             
  -------------------------------------- -------- ------------- -------------------- -----------
  Days to return to play at any level                                                 

   Docking                               4        423 ± 54.5    96.6\                .296
                                                                (--88.8 to 282.0)    

   Modified Jobe                         28       519 ± 178.1                        

  Days to return to play at same level                                                

   Docking                               2        476 ± 37.5    77.6\                .502
                                                                (--159.2 to 314.4)   

   Modified Jobe                         20       553 ± 156.8                        

                                         Yes, n   No, n         \% Yes               *P* Value

  Return to play at any level                                                         

   Docking                               4        3             57.1                 .347

   Modified Jobe                         28       8             77.8                 

  Return to play at same level                                                        

   Docking                               2        5             28.6                 .240

   Modified Jobe                         20       16            55.6                 

  Subsequent elbow injury                                                             

   Docking                               2        5             28.6                 .999

   Modified Jobe                         10       26            27.8                 

  Subsequent forearm injury                                                           

   Docking                               0        7             0.0                  .999

   Modified Jobe                         3        33            8.3                  

  Subsequent elbow surgery                                                            

   Docking                               1        6             14.3                 .999

  Modified Jobe                          9        27            25.0                 

   Subsequent UCL reconstruction                                                      

   Docking                               0        7             0.0                  .999

   Modified Jobe                         3        33            8.3                  
  ----------------------------------------------------------------------------------------------

*^a^*UCL, ulnar collateral ligament.

Major league players had a significantly higher rate of RTP (73.1%) compared with minor league players (39.5%) (*P* = .01). However, no significant difference was found in RSL, time to RTP, or career length between MLB and MiLB players (*P* value range, .19-.54). Additionally, no significant difference was noted in RTP, RSL, time to RTP, or career length based on player handedness (*P* value range, .08-.78), role as a starter or relief pitcher (*P* value range, .62-.92), or player age at the time of surgery (*P* value range, .06-.94). Finally, the number of concomitant procedures did not significantly affect RTP (*P* = .19), RSL (*P* = .85), time to RTP (*P* = .24), or career length (*P* = .15).

Discussion {#section4-2325967119864104}
==========

Because the results of revision procedures often differ from those of primary surgeries, epidemiologic and outcome data of revision UCL reconstruction may play a crucial role in patient care. This study demonstrated a trend toward increasing numbers of revision UCL reconstructions between 2010 and 2016 among professional baseball players. During this period, the most commonly used graft was an autograft hamstring tendon, and the majority of procedures were performed with the modified Jobe technique. More than three-fourths of players (76.6%) who underwent revision returned to play, but just over half (55.3%) returned to the same level of play following surgery. No statistically significant differences were found in the rates of subsequent injuries or subsequent surgeries between docking and modified Jobe techniques or between hamstring and palmaris longus autograft constructs.

The trend we found toward increasing numbers of revision UCL reconstructions being performed in professional baseball players is in agreement with other studies on the topic. Liu et al^[@bibr21-2325967119864104]^ reported a revision rate of 13.2% (31/235) in professional baseball players who underwent UCL reconstruction between 1999 and 2016. This marked a considerable increase from the revision rates reported in earlier studies, which ranged from 1.0 to 1.9%^[@bibr1-2325967119864104],[@bibr27-2325967119864104]^; however, those studies included other overhead athletes in addition to professional baseball players. Similarly, Wilson et al^[@bibr31-2325967119864104]^ reported a revision rate of 15% (40/271) in a cohort of professional baseball players. In that work, the authors cited earlier age at the time of the index surgery, poor adherence to pitched-inning limits, and year-round throwing as potential causes for rising revision rates.^[@bibr31-2325967119864104]^ Given the apparent complexities and inferior outcomes of revision surgery, this increase in revision rate may be cause for concern. Revision UCL reconstructions have been shown to result in lower RTP rates and higher complication rates compared with primary procedures in some studies.^[@bibr6-2325967119864104],[@bibr17-2325967119864104],[@bibr21-2325967119864104],[@bibr25-2325967119864104]^

The majority of revisions in this study were completed through use of the modified Jobe technique, and when combined with those who underwent the docking technique, they accounted for nearly 85% of the cases. Currently, data reporting on the surgical techniques used at the time of revision UCL reconstructions are lacking in the literature. Specifically regarding primary surgery, a recent survey of MLB team orthopaedic surgeons found that 56.7% of respondents preferred the docking technique and 20% preferred the modified Jobe technique. Furthermore, 63.3% reported that the palmaris longus tendon was their preferred graft choice.^[@bibr11-2325967119864104]^ These preferences for primary surgeries differ from the current investigation into revision UCL reconstruction, which demonstrated a predilection toward the modified Jobe technique and a hamstring autograft. This may reflect the fact that the palmaris was used for the primary procedure (and thus was no longer available for the revision surgery), or it could be that the surgeon believed that a large graft (ie, gracilis or semitendinosus) was indicated in the revision setting.

Although both techniques have been shown to provide acceptable outcomes,^[@bibr10-2325967119864104],[@bibr18-2325967119864104]^ a systematic review by Watson et al^[@bibr29-2325967119864104]^ studying primary surgeries demonstrated a significantly higher RTP rate and lower complication rate when the docking technique was used versus the Jobe or modified Jobe. Paletta et al^[@bibr28-2325967119864104]^ reported in a cadaveric study that the docking technique may offer an initial biomechanical advantage over the Jobe construct; however, on the whole, biomechanical studies have failed to consistently demonstrate the superiority of any particular surgical technique.^[@bibr3-2325967119864104],[@bibr10-2325967119864104],[@bibr16-2325967119864104],[@bibr22-2325967119864104],[@bibr23-2325967119864104],[@bibr26-2325967119864104]^ The current study did not show any statistically significant differences in subsequent injuries or subsequent surgeries between surgical techniques or graft constructs. The high rate found in the current study of subsequent elbow injury (29.8%) following revision UCL is consistent with other studies examining subsequent injury rates in professional baseball players undergoing primary UCL reconstruction.^[@bibr8-2325967119864104],[@bibr13-2325967119864104]^ A recent study examining 195 primary UCL reconstructions in professional baseball players found a subsequent injury rate of 50.1% to 56.4%.^[@bibr8-2325967119864104]^ The mean RTP time of 484 days (16 months) in the current study is shorter than RTP times previously reported in revision UCL reconstruction patients, which ranged from 18.9 to 20.76 months.^[@bibr17-2325967119864104],[@bibr21-2325967119864104]^ This discrepancy may be attributable to the fact that these later studies included a relatively small number of patients. In the context of primary UCL reconstruction, Erickson et al^[@bibr9-2325967119864104]^ reported no difference in outcome scores between surgical technique (docking vs double-docking) or graft types (palmaris autograft, hamstring autograft, and allograft). A robust comparative analysis of surgical technique specific to revision UCL reconstructions was not found in the literature. In the absence of any clear superiority, surgical technique selection ultimately depends on the surgeon's expertise and preference.^[@bibr14-2325967119864104]^

Several limitations in the present study merit discussion. As with all medical records, the validity of the data was reliant on the accurate documentation of player medical information, diagnoses, and outcomes into the HITS database. Although medical personnel and athletic trainers employed by professional baseball organizations are well trained, the potential for errors in data entry is always present. Additionally, preoperative treatments, the exact nature of the injury (site of ligament failure, severity of injury, etc), and postoperative rehabilitation programs were not consistently documented, thus limiting the comparisons that can be drawn about superiority of technique and graft construct. Finally, although this work represents the largest known study of revision UCL reconstructions in professional baseball players, it still may not have been sufficiently powered to detect differences among all of the variables studied. Despite these limitations, the study has a number of strengths. The inclusion of a homogeneous group of professional baseball pitchers allows for more precise comparisons and minimizes confounding variables that may be present if position players and other overhead athletes were included. The use of a comprehensive database (HITS) that was cross-referenced with operative reports allowed for a more complete and accurate representation of the epidemiologic patterns of these injuries. As such, this study provides a thorough epidemiologic report of RTP, RSL, subsequent injuries, and surgical details of revision UCL reconstruction in professional baseball players.

Conclusion {#section5-2325967119864104}
==========

This report detailing revision UCL reconstruction among professional baseball pitchers showed a trend toward increasing numbers of revisions being performed, a finding consistent with other recent studies. The overall RTP percentage was higher than previously reported (76.6%); however, significantly fewer (55.3%) players returned to the same level of play. This work also demonstrated decreased RTP times (mean ± SD, 484 ± 117.3 days) compared with other investigations. The modified Jobe was the most commonly used surgical technique, and the 2 most commonly used graft constructs were hamstring autograft and palmaris longus autograft. Although this analysis did not reveal any statistically significant comparative differences between surgical techniques or graft constructs, future studies involving head-to-head comparisons of these surgical variables, specific to revision UCL reconstruction, may be helpful in improving player outcomes and career performance.
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